 |
| |
 | | Follow-up | |
- See patients treated for anthrax in follow-up for clinical evaluation and appropriate laboratory studies.
- Monitor patients on antibiotic prophylaxis for anthrax for medication side effects and signs or symptoms of systemic disease.
| | Elements of Follow-up for Anthrax (table)
|
|
See patients treated for anthrax in follow-up for clinical evaluation and appropriate laboratory studies.  |
- Obtain a follow-up chest x-ray, chest CT, or both to monitor patients treated for inhalational anthrax.
- Perform a follow-up skin exam to document clearing of cutaneous anthrax.
- Send follow-up CBC and liver enzymes if they were previously abnormal or if the patient is on antibiotics that can cause abnormalities.
- During a bioterrorist attack with anthrax, follow patients with cutaneous anthrax for development of signs of inhalational anthrax.
- Follow patients after they have completed therapy to make certain disease does not recur.
- See table Elements of Follow-up for Anthrax.
| Background | Back to top
|
Monitor patients on antibiotic prophylaxis for anthrax for medication side effects and signs or symptoms of systemic disease. |
- Ask patients about adherence to the prophylactic regimen.
- Monitor patients for drug side effects.
- Obtain a chest x-ray, chest CT (or both), and blood cultures on any patient receiving anthrax prophylaxis who develops fevers, constitutional symptoms, or shortness of breath.
- See table Elements of Follow-up for Anthrax.
| Background | Back to top
| | | FAQs |
|
| Barbara Robinson-Dunn, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Demetrios N. Kyriacou, MD, PhD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Niklas Mackler, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Sandro Cinti, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. |
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|
Anthrax
